Tukysa (tucatinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tukysa (tucatinib), covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Tucatinib+Trastuzumab+Eribulin in HER2+ MBC [Phase 2]